title: Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor.
authors: Department of Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
authors: J S
authors: JS
authors: Burdick
authors: E
authors: E
authors: Chung
authors: G
authors: G
authors: Tanner
authors: M
authors: M
authors: Sun
authors: J E
authors: JE
authors: Paciga
authors: J Q
authors: JQ
authors: Cheng
authors: K
authors: K
authors: Washington
authors: J R
authors: JR
authors: Goldenring
authors: R J
authors: RJ
authors: Coffey
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects; D066246:ErbB Receptors / Q000032:analysis / Q000276:immunology*; D017809:Fatal Outcome; D005753:Gastric Mucosa / Q000737:chemistry / Q000473:pathology; D005758:Gastritis, Hypertrophic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications; D008297:Male; D008875:Middle Aged; D010295:Parietal Cells, Gastric / Q000473:pathology; D011230:Precancerous Conditions / Q000150:complications / Q000188:drug therapy*; D014839:Vomiting / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D003287:Contrast Media; D066246:ErbB Receptors